|
Sept. 02, 2020 |
|
|
Jan. 04, 2024 |
|
|
jRCTs041200041 |
The effects of b-lactolin on cognitive function for mild cognitive decline -A randomized double-blind placebo controlled trial- |
|
The effects of b-lactolin on cognitive function for mild cognitive decline -A randomized double-blind placebo controlled trial- |
Muto Shigeki |
||
Seirei Medical Checkup Center |
||
2-35-8, Sumiyoshi, Chuo-ku, Hamamatu-shi, Shizuoka |
||
+81-53-473-5506 |
||
smuto@sis.seirei.or.jp |
||
Ikeda Takayuk |
||
Seirei Medical Checkup Center |
||
2-35-8, Sumiyoshi, Chuo-ku, Hamamatu-shi, Shizuoka |
||
+81-53-439-1111 |
||
t-ikeda@sis.seirei.or.jp |
Complete |
Sept. 02, 2020 |
||
| 80 | ||
Interventional |
||
randomized controlled trial |
||
double blind |
||
placebo control |
||
parallel assignment |
||
prevention purpose |
||
1) Age: Men and women 50 years or older when consent is obtained |
||
1) Those who are currently undergoing treatment or follow-up for diseases (Epilepsy, stroke, dementia,Parkinson's disease, etc.) of the cranial nervous system |
||
| 50age old over | ||
| No limit | ||
Both |
||
Mild cognitive impairment |
||
<Ingestion of research food> |
||
Mild cognitive impairment |
||
Cognitive function |
||
Cognitive function assessments (MMSE-J, MoCA-J) |
||
Cognitive function assessments, mental funciton assessments, QOL assessments |
||
| Kirin Holdings Company, Limited | |
| Not applicable |
| Clinical Research Review Board of Hamamatsu University School of Medicine | |
| 1-20-1 Handayama, Chuo-ku, Hamamatsu city, Shizuoka,, Shizuoka | |
+81-53-435-2680 |
|
| kenkyou.s@hama-med.ac.jp | |
| Approval |
none |